Literature DB >> 18836469

Positive and negative influences of regulatory T cells on tumour immunity.

A M Gallimore1, A K Simon.   

Abstract

Clinicians and scientists have long questioned whether the immune system has a role in destroying cancerous tissue. Studies performed in animal models have, however, recently revealed that the immune system can, at least in principle, effectively control tumours. In parallel with these findings, a large body of evidence indicates that although the immune system has the capacity to control tumours, there are also regulatory mechanisms that subdue these responses. A major challenge of tumour immunotherapy, therefore, is to find ways of disabling these regulatory functions while restoring or priming any immune responses that are protective.

Entities:  

Mesh:

Year:  2008        PMID: 18836469     DOI: 10.1038/onc.2008.269

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  25 in total

Review 1.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

Review 2.  Cancer immunotherapy: a promising dawn in cancer research.

Authors:  Banashree Bondhopadhyay; Sandeep Sisodiya; Atul Chikara; Asiya Khan; Pranay Tanwar; Dil Afroze; Neha Singh; Usha Agrawal; Ravi Mehrotra; Showket Hussain
Journal:  Am J Blood Res       Date:  2020-12-15

Review 3.  Adaptive control of innate immunity.

Authors:  Anil Shanker
Journal:  Immunol Lett       Date:  2010-04-13       Impact factor: 3.685

4.  Activation of regulatory T cells instigates functional down-regulation of cytotoxic T lymphocytes in human breast cancer.

Authors:  Chao-Hsu Li; Wen-Hong Kuo; Wen-Chun Chang; Su-Cheng Huang; King-Jen Chang; Bor-Ching Sheu
Journal:  Immunol Res       Date:  2011-10       Impact factor: 2.829

5.  Methionine enkephalin (MENK) inhibits tumor growth through regulating CD4+Foxp3+ regulatory T cells (Tregs) in mice.

Authors:  Xuan Li; Yiming Meng; Nicolas P Plotnikoff; Gene Youkilis; Noreen Griffin; Enhua Wang; Changlong Lu; Fengping Shan
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

6.  Regulatory T cells with multiple suppressive and potentially pro-tumor activities accumulate in human colorectal cancer.

Authors:  Eleonora Timperi; Ilenia Pacella; Valeria Schinzari; Chiara Focaccetti; Luca Sacco; Francesco Farelli; Roberto Caronna; Gabriella Del Bene; Flavia Longo; Antonio Ciardi; Sergio Morelli; Anna Rita Vestri; Piero Chirletti; Vincenzo Barnaba; Silvia Piconese
Journal:  Oncoimmunology       Date:  2016-04-25       Impact factor: 8.110

Review 7.  Immunomodulatory effects of deacetylase inhibitors: therapeutic targeting of FOXP3+ regulatory T cells.

Authors:  Liqing Wang; Edwin F de Zoeten; Mark I Greene; Wayne W Hancock
Journal:  Nat Rev Drug Discov       Date:  2009-10-26       Impact factor: 84.694

8.  Distribution of Regulatory T-Cells and Other Phenotypes of T-Cells in Tumors and Regional Lymph Nodes of Colorectal Cancer Patients.

Authors:  Keisuke Kazama; Junya Otake; Tetsuta Satoyoshi; Manabu Shiozawa; Nobuhiro Sugano; Sumito Sato; Yosuke Atsumi; Kazuki Kano; Masaaki Murakawa; Yukio Maezawa; Itaru Hashimoto; Masakatsu Numata; Takashi Oshima; Norio Yukawa; Yasushi Rino; Tetsuro Sasada; Munetaka Masuda
Journal:  In Vivo       Date:  2020 Mar-Apr       Impact factor: 2.155

Review 9.  The skin microbiome and immune system: Potential target for chemoprevention?

Authors:  Mohammad Asif Sherwani; Saba Tufail; Anum Fatima Muzaffar; Nabiha Yusuf
Journal:  Photodermatol Photoimmunol Photomed       Date:  2017-08-30       Impact factor: 3.135

10.  Tunable chemokine production by antigen presenting dendritic cells in response to changes in regulatory T cell frequency in mouse reactive lymph nodes.

Authors:  Valentina Dal Secco; Cristiana Soldani; Claire Debrat; François Asperti-Boursin; Emmanuel Donnadieu; Antonella Viola; Adelaida Sarukhan
Journal:  PLoS One       Date:  2009-11-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.